Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,698 | -25,113 | 4,848 | 809 | -19,997 |
| Depreciation Amortization | 1,143 | 2,320 | 3,086 | 2,787 | 1,828 |
| Income taxes - deferred | 2,653 | 1,333 | -4,285 | 981 | -2,036 |
| Accounts receivable | 8,670 | 5,448 | -7,441 | 4,205 | 6,629 |
| Other Working Capital | 7,308 | 5,348 | -6,076 | 2,236 | 6,302 |
| Other Operating Activity | -9,163 | 16,540 | 13,178 | -2,109 | 3,691 |
| Operating Cash Flow | $4,913 | $5,877 | $3,311 | $8,909 | $-3,584 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -60 | -2,866 | -982 | -11 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -824 |
| Other Investing Activity | -6,378 | -7,318 | -6,012 | -3,229 | -16,454 |
| Investing Cash Flow | $-6,378 | $-7,378 | $-8,878 | $-4,211 | $-17,289 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 3,254 | N/A | 6,338 |
| Common Stock Issued | 1,690 | N/A | 3,863 | N/A | N/A |
| Other Financing Activity | -278 | -161 | -163 | -6,458 | -792 |
| Financing Cash Flow | $1,411 | $-161 | $6,954 | $-6,458 | $5,545 |
| Exchange Rate Effect | 189 | 15 | 219 | 80 | 114 |
| Beginning Cash Position | 39 | 1,685 | 80 | 1,759 | 16,972 |
| End Cash Position | 173 | 39 | 1,685 | 80 | 1,759 |
| Net Cash Flow | $134 | $-1,646 | $1,605 | $-1,679 | $-15,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,913 | 5,877 | 3,311 | 8,909 | -3,584 |
| Capital Expenditure | N/A | -60 | -2,869 | -982 | -33 |
| Free Cash Flow | 4,913 | 5,818 | 441 | 7,927 | -3,617 |